India Quizartinib FLT3 Inhibitor 53mg Daily

Quizartinib is a FLT3 inhibitor used for treating AML that comes back or doesn’t respond to treatment in people with FLT3-ITD mutations. The drug comes in two tablet strengths: 17.7 mg and 26.5 mg, both with a film coating. You typically start with 53 mg a day once you’ve adjusted the dose gradually.

Each bottle has 28 tablets, which makes it easy to tweak your dose if needed. Quizartinib blocks FLT3 signaling, a key part of how AML with FLT3-ITD mutations grows. The efficacy and safety of quizartinib have been established in clinical trials involving patients with relapsed or refractory AML who have FLT3-ITD mutations, indicating its potential as a targeted therapeutic option for this patient population.